HINOVA Trademark

Trademark Overview


On Thursday, January 18, 2024, a trademark application was filed for HINOVA with the United States Patent and Trademark Office. The USPTO has given the HINOVA trademark a serial number of 98364705. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Sunday, March 29, 2026. This trademark is owned by Hinova Pharmaceuticals Inc.. The HINOVA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical devices, namely, devices for diagnosis and treatment of cancers, hyperuricemia associated disorders and conditions, immune disorder and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions

Pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical products for treatment of cancers, hyperuricemia associated disorders and conditions, immune disorders and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions
hinova

General Information


Serial Number98364705
Word MarkHINOVA
Filing DateThursday, January 18, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateSunday, March 29, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe word(s) "HINOVA" has no meaning in a foreign language.
Goods and ServicesMedical devices, namely, devices for diagnosis and treatment of cancers, hyperuricemia associated disorders and conditions, immune disorder and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions
Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations and pharmaceutical products for treatment of cancers, hyperuricemia associated disorders and conditions, immune disorders and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions
Description of MarkThe mark consists of the name "HINOVA" with an arc extending from the top of the "I".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, January 18, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHinova Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChengdu, Sichuan 610041
CN

Party NameHinova Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChengdu, Sichuan 610041
CN

Trademark Events


Event DateEvent Description
Thursday, January 18, 2024NEW APPLICATION ENTERED
Friday, May 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 24, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, August 14, 2024ASSIGNED TO EXAMINER
Wednesday, August 21, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 21, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 10, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, January 10, 2025EXAMINERS AMENDMENT E-MAILED
Friday, January 10, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 10, 2025EXAMINER'S AMENDMENT ENTERED
Friday, January 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 1, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, October 1, 2025SOU EXTENSION 1 FILED
Wednesday, October 1, 2025SOU EXTENSION 1 GRANTED
Thursday, October 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 28, 2026SOU TEAS EXTENSION RECEIVED
Saturday, March 28, 2026SOU EXTENSION 2 FILED
Sunday, March 29, 2026SOU EXTENSION 2 GRANTED
Sunday, March 29, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED